Videos
Embracing New Approaches to Seizure Control Beyond Surgery: Gregory Krauss, MD
December 3rd 2023The professor of neurology at Johns Hopkins University School of Medicine discussed the traditional view of epilepsy treatment and how the paradigm has shifted to provide new treatments to achieve seizure freedom for drug-resistant patients. [WATCH TIME: 5 minutes]
A Paradigm Shift in Preventing Drug-Resistant Epilepsy: Pavel Klein, MD
December 1st 2023The director of the Mid-Atlantic Epilepsy & Sleep Center and adjunct associate professor of neurology at George Washington University discussed the advancements in epilepsy research, especially for drug-resistant epilepsy, to be presented at AES 2023. [WATCH TIME: 4 minutes]
Exploring the Hidden Burdens of Persistent Seizures for Patients: Danielle Becker, MD, MS, FAES
December 1st 2023The division director of epilepsy and associate professor of neurology at The Ohio State University Wexner Medical Center discussed the profound repercussion of ongoing seizures for patients with epilepsy which is to be presented at AES 2023 in SK Life Science’s symposium. [WATCH TIME: 5 minutes]
Role of Fluid Biomarkers and GFAP in Neurodegeneration: Charles Bernick, MD
November 30th 2023The neurologist at Cleveland Clinic provided perspective on the reasons to study individuals exposed to repetitive head impacts and the lessons learned about monitoring glial fibrillary acidic protein over time. [WATCH TIME: 4 minutes]
Eptinezumab’s Real-World Impact as Chronic Migraine Treatment: Amaal Starling, MD, FAHS, FAAN
November 28th 2023The associate professor in the department of neurology at Mayo Clinic College of Medicine talked about findings from a real-world study assessing eptinezumab among patients with chronic migraine which was presented at the AHS Scottsdale Headache Symposium 2023. [WATCH TIME: 4 minutes]
New Frontiers in the Prevention of Seizures, Gene Therapy in Epilepsy: William Gallentine, DO
November 28th 2023The interim chief of pediatric neurology at Stanford Medicine Children’s Health discussed progress in preventing seizures among patients with epilepsy, the potential for gene-targeted therapies, and the importance of localizing where seizures are coming from. [WATCH TIME: 5 minutes]
Expanding the Migraine Treatment Protocol Beyond CGRPs: Emad Estemalik, MD
November 27th 2023The director of the headache section at Cleveland Clinic detailed some of the emerging nonpharmacological preventive methods for migraine, as well as where research is headed following the explosion of CGRP-targeting therapies. [WATCH TIME: 6 minutes]
Effectiveness of Midazolam for Seizure Cluster Management: Kamil Detyniecki, MD
November 21st 2023The associate professor of clinical neurology at the University of Miami Miller School of Medicine talked about findings from a recent post hoc analysis assessing the FDA-approved treatment of midazolam for seizure clusters. [WATCH TIME: 3 minutes]
Phase II Clinical Trial: Tolebrutinib
Jiwon Oh, MD, PhD, FRCPC, provides an overview of phase II results of tolebrutinib for the treatment of multiple sclerosis.
Identifying the Right Candidate for Epilepsy Surgery: William Gallentine, DO
November 20th 2023The interim chief of pediatric neurology at Stanford Medicine Children’s Health provided insight on advances the screening for epilepsy surgery and the factors that pediatric neurologists should consider. [WATCH TIME: 5 minutes]
Advancements and Updates to the Treatment Algorithm of Migraine: Emad Estemalik, MD
November 19th 2023The director of the headache section at Cleveland Clinic’s Neurological Institute gave an administrative perspective on the changes to how patients with migraine are cared for, led by significant developments in recent years. [WATCH TIME: 4 minutes]
